213 related articles for article (PubMed ID: 15027176)
1. [Further studies on the relationship between benign prostatic hyperplasia and prostatitis].
Xia T
Zhonghua Nan Ke Xue; 2004 Feb; 10(2):83-5. PubMed ID: 15027176
[TBL] [Abstract][Full Text] [Related]
2. [Inflammation and benign prostatic hyperplasia: cause or consequence?].
Robert G; Salagierski M; Schalken JA; de La Taille A
Prog Urol; 2010 Jun; 20(6):402-7. PubMed ID: 20538203
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
4. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
5. [Benign prostate hyperplasia with chronic prostatitis: an update].
Ma Y; Zhang WL
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
[TBL] [Abstract][Full Text] [Related]
6. Prostatitis in benign prostatic hyperplasia: a histological, bacteriological and clinical study.
Bedalov G; Vucković I; Fridrih S; Bruk M; Puskar D; Bartolin Z
Acta Med Croatica; 1994; 48(3):105-9. PubMed ID: 7532045
[TBL] [Abstract][Full Text] [Related]
7. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
8. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
Pawlicki B; Zieliński H; Dabrowski M
Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
[TBL] [Abstract][Full Text] [Related]
9. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of benign prostate hyperplasia with prostatitis].
Long Z; He L; Zhong K; Zhang Y; Yue D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):381-5. PubMed ID: 20448364
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of platelet-derived growth factor with benign prostatic hyperplasia].
Chu J; Zhong HX
Zhonghua Nan Ke Xue; 2007 Oct; 13(10):932-5. PubMed ID: 17977330
[TBL] [Abstract][Full Text] [Related]
12. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
[TBL] [Abstract][Full Text] [Related]
13. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
[TBL] [Abstract][Full Text] [Related]
14. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
Wu XJ; Yang LY; Zhang XZ
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
[TBL] [Abstract][Full Text] [Related]
15. [Optimal treatment of benign prostatic hyperplasia (BPH) with comorbid chronic prostatitis (category IIIA)].
Golubchikov VA; Sitnikov NV; Kochetov AG; Perekhodov SN; Sidorov OV; Roiuk RV; Nagoprniuk VN; Tsibizov DN
Urologiia; 2005; (4):9-12. PubMed ID: 16158737
[TBL] [Abstract][Full Text] [Related]
16. HMGB1: a potential target for treatment of benign prostatic hyperplasia.
Rui X; Shengli M; Zhankui J; Guofu P; Jinjian Y
Med Hypotheses; 2013 Nov; 81(5):892-5. PubMed ID: 23948596
[TBL] [Abstract][Full Text] [Related]
17. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.
Alcaraz A; Hammerer P; Tubaro A; Schröder FH; Castro R
Eur Urol; 2009 Apr; 55(4):864-73. PubMed ID: 19027219
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological association between BPH and prostatitis.
Rijal A; Gautam K
Nepal Med Coll J; 2011 Sep; 13(3):152-6. PubMed ID: 22808803
[TBL] [Abstract][Full Text] [Related]
19. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate.
Shakya G; Malla S; Shakya KN
Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207
[TBL] [Abstract][Full Text] [Related]
20. Etiology of benign prostatic hyperplasia.
Lee C; Kozlowski JM; Grayhack JT
Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
